P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

October 2005

Features

Impact of Inhaled Corticosteroid–Induced Oropharyngeal Side Effects on Treatment Patterns and Costs in Asthmatic Patients: Results from a Delphi Panel

Inhaled corticosteroid (ICS) therapy can be associated not only with rare systemic adverse events (ADEs) but also, more commonly, with oropharyngeal ADEs. The authors investigate the economic burden of ICS treatment.
Michael Kaliner, MD; Alpesh Amin, MD, MBA, Ronald Gehling, MD, PharmD, Concetta Crivera, PharmD, Evelyn Chiao, PharmD, Tejal Vishalpura, PharmD, and Thomas Bramley, PhD

Clinical and Economic Outcomes of Prolonged Postoperative Ileus in Patients Undergoing Hysterectomy and Hemicolectomy

The authors examine the clinical and economic implications of PPOI within a patient population undergoing abdominal surgeries at a major urban academic medical center.
Christopher G. Salvador, PharmD, Mirko Sikirica, PharmD, Adam Evans, BS, Laura Pizzi, PharmD, MPH, and Neil Goldfarb, BA

Pharmaceutical Approval Update

Dr. Goldenberg discusses new indications for levofloxacin (Levaquin® Leva-pak), an antibiotic for patients with acute bacterial sinusitis and community-acquired pneumonia; valsartan (Diovan®), for left ventricular failure or left ventricular dysfunction; and dapsone gel (Aczone®), a topical therapy for acne vulgaris.
Marvin M. Goldenberg, PhD, RPh, MS

Meeting Highlights

European Society of Cardiology, 2005 Congress

With advances in the treatment of MI, cardiologists are now focusing on improving the safety of drugs for heart disease. The author presents some new findings on aspirin, fondaparinux, enoxaparin, heparin, clopidogrel, and fish oil for prevention and treatment.
Reuben B. David

Departments

Editorial

VNSNY—Bringing the Caring Home

David Nash, MD, MBA, describes the services provided by the Visiting Nurse Service of New York, which has cared for patients at home for more than a century.
David B. Nash, MD, MBA

Medication Errors

Avoiding Opiate Toxicity with Patient-Controlled Analgesia by Proxy

Matthew Grissinger, RPh, FASCP, explains how to avoid opiate toxicity with patient-controlled analgesia.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

FTC Report Partially Addresses PBMs and Medicare . . . But Does Not Clarify Formulary Policies

The Federal Trade Commission’s recent report examines PBMs and mail-order pharmacies and how Medicare drug prices will be affected by this relationship.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.

Drug Forecast

Erlotinib (Tarceva®): A Brief Overview

The authors review erlotinib (Tarceva®) for the treatment of non–small-cell lung cancer.
Donna Clay, RPh, Yvette M. Lipman, PharmD, and Mary Ellen Bonk, PharmD